<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Fri, 28 Aug 2026 00:01:50 -0400--><rss version="2.0">
    <channel>
        <title>Mineralys Therapeutics, Inc. (MLYS) Press Releases</title>
        <link>https://ir.mineralystx.com/news-events/press-releases/rss</link>
        <description></description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/mineralystx/files/theme/images/logo-email.png</url>
                <title>Mineralys Therapeutics, Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[Mineralys Therapeutics to Participate in the Wells Fargo 21st Annual Healthcare Conference]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.mineralystx.com/news-events/press-releases/detail/113/mineralys-therapeutics-to-participate-in-the-wells-fargo</link>
                <pubDate>Wed, 26 Aug 26 08:00:00 -0400</pubDate>
                <guid>https://ir.mineralystx.com/news-events/press-releases/detail/113/mineralys-therapeutics-to-participate-in-the-wells-fargo</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Mineralys Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.mineralystx.com/news-events/press-releases/detail/112/mineralys-therapeutics-reports-inducement-award-under</link>
                <pubDate>Thu, 13 Aug 26 16:05:00 -0400</pubDate>
                <guid>https://ir.mineralystx.com/news-events/press-releases/detail/112/mineralys-therapeutics-reports-inducement-award-under</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Mineralys Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.mineralystx.com/news-events/press-releases/detail/111/mineralys-therapeutics-reports-second-quarter-2026</link>
                <pubDate>Tue, 11 Aug 26 16:05:00 -0400</pubDate>
                <guid>https://ir.mineralystx.com/news-events/press-releases/detail/111/mineralys-therapeutics-reports-second-quarter-2026</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Mineralys Therapeutics to Announce Second Quarter 2026 Financial Results and Host Conference Call on Tuesday, August 11, 2026]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.mineralystx.com/news-events/press-releases/detail/110/mineralys-therapeutics-to-announce-second-quarter-2026</link>
                <pubDate>Tue, 04 Aug 26 08:00:00 -0400</pubDate>
                <guid>https://ir.mineralystx.com/news-events/press-releases/detail/110/mineralys-therapeutics-to-announce-second-quarter-2026</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.mineralystx.com/news-events/press-releases/detail/109/mineralys-therapeutics-reports-inducement-awards-under</link>
                <pubDate>Mon, 27 Jul 26 16:01:00 -0400</pubDate>
                <guid>https://ir.mineralystx.com/news-events/press-releases/detail/109/mineralys-therapeutics-reports-inducement-awards-under</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.mineralystx.com/news-events/press-releases/detail/108/mineralys-therapeutics-presents-late-breaking-data-on</link>
                <pubDate>Sun, 14 Jun 26 10:00:00 -0400</pubDate>
                <guid>https://ir.mineralystx.com/news-events/press-releases/detail/108/mineralys-therapeutics-presents-late-breaking-data-on</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Mineralys Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.mineralystx.com/news-events/press-releases/detail/107/mineralys-therapeutics-to-participate-in-the-goldman-sachs</link>
                <pubDate>Mon, 08 Jun 26 16:05:00 -0400</pubDate>
                <guid>https://ir.mineralystx.com/news-events/press-releases/detail/107/mineralys-therapeutics-to-participate-in-the-goldman-sachs</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Mineralys Therapeutics to Present Late-Breaking Data on Lorundrostat at The Endocrine Society Annual Meeting (ENDO 2026)]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.mineralystx.com/news-events/press-releases/detail/106/mineralys-therapeutics-to-present-late-breaking-data-on</link>
                <pubDate>Mon, 08 Jun 26 07:00:00 -0400</pubDate>
                <guid>https://ir.mineralystx.com/news-events/press-releases/detail/106/mineralys-therapeutics-to-present-late-breaking-data-on</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Mineralys Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.mineralystx.com/news-events/press-releases/detail/105/mineralys-therapeutics-announces-pricing-of-150-million</link>
                <pubDate>Wed, 03 Jun 26 06:05:00 -0400</pubDate>
                <guid>https://ir.mineralystx.com/news-events/press-releases/detail/105/mineralys-therapeutics-announces-pricing-of-150-million</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Mineralys Therapeutics Announces Repurchase of Royalty Obligations in Tanabe License Agreement and Concurrent Financing]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.mineralystx.com/news-events/press-releases/detail/104/mineralys-therapeutics-announces-repurchase-of-royalty</link>
                <pubDate>Wed, 03 Jun 26 06:00:00 -0400</pubDate>
                <guid>https://ir.mineralystx.com/news-events/press-releases/detail/104/mineralys-therapeutics-announces-repurchase-of-royalty</guid>
                                                                            </item>
            </channel>
</rss>